Electroacupuncture delays the progression of juvenile collagen-induced arthritis via regulation NLRP3/ NF-κB signaling pathway -mediated pyroptosis and its influence on autophagy.

Researchers investigated how electroacupuncture (EA) might help children with juvenile idiopathic arthritis (JIA), the most common form of arthritis affecting children. JIA causes chronic inflammation in the joints, leading to pain, disability, and damage to the tissue lining the joints (synovium). Using young rats with arthritis, scientists discovered that EA works through several important biological mechanisms. The study found that a protein called NLRP3 plays a key role in driving inflammation in juvenile arthritis. When NLRP3 levels are high, it triggers a chain reaction involving inflammatory pathways (NF-κB signaling) and a form of inflammatory cell death called pyroptosis. EA treatment was shown to reduce NLRP3 levels and interrupt this harmful inflammatory cycle. Additionally, EA helped restore autophagy, the body's natural cellular cleaning process that removes damaged components and helps cells stay healthy. This autophagy restoration appeared important for reducing inflammation. The researchers confirmed their findings by artificially increasing NLRP3 in some rats, which made arthritis worse, while EA treatment reversed these negative effects. Rats receiving EA showed less joint inflammation, reduced synovial tissue damage, and slower arthritis progression overall. For families considering acupuncture for childhood arthritis, this research suggests EA may offer benefits by targeting multiple inflammation pathways simultaneously, potentially slowing disease progression and protecting joint tissue. However, this study was conducted in animals, and more human studies are needed to confirm these benefits in children with JIA. Parents should consult with qualified, licensed acupuncturists experienced in pediatric care when considering this treatment option.

This study investigated electroacupuncture (EA) mechanisms in juvenile collagen-induced arthritis (CIA) using 2-3 week old Sprague-Dawley rats. Researchers employed adeno-associated virus to overexpress NLRP3 in knee joints, demonstrating that NLRP3 upregulation exacerbates synovial inflammation via NF-κB pathway activation and pyroptosis induction while impairing autophagy. EA treatment significantly reduced NLRP3 expression, inhibited the NLRP3-NF-κB inflammatory axis, and restored autophagy capacity in synovial tissue. Histopathological analysis confirmed EA reduced synovial degeneration and slowed juvenile CIA progression. The study establishes that EA's therapeutic effects operate through multi-mechanistic pathways: suppressing inflammasome activation, modulating pyroptotic cell death, and enhancing autophagic cellular maintenance. Clinical implications suggest EA may offer disease-modifying potential in pediatric inflammatory arthritis by targeting upstream inflammatory regulators. The trial (NCT10203935) provides preclinical evidence supporting EA as an adjunctive therapy for JIA, though human pediatric trials are needed to establish clinical efficacy, optimal treatment parameters, and safety profiles in this population.